Published on 16 July 2024

Treatment of osteoarthritis of the knee and the hip via glucocorticoid injection

Osteoarthritis of the knee and the hip are two of the most common joint diseases among adults. The damage to the joint’s cartilage causes pain and restricts mobility. One treatment of knee and hip osteoarthritis entails administering injections of glucocorticoids (steroid hormones) into the joint. This report investigates the safety and the efficacy of this treatment method, together with its cost/benefit ratio, its impact on cost budgets and further ethical, legal, societal and organisational issues and concerns.

Further information

< Zurück zu HTA-Projekte

Federal Office of Public Health FOPH

Health insurance benefits Division
Health Technology Assessment Section
Schwarzenburgstrasse 157
Switzerland - 3003 Bern